vs
Side-by-side financial comparison of Elanco Animal Health Inc (ELAN) and LCI INDUSTRIES (LCII). Click either name above to swap in a different company.
Elanco Animal Health Inc is the larger business by last-quarter revenue ($1.1B vs $932.7M, roughly 1.2× LCI INDUSTRIES). LCI INDUSTRIES runs the higher net margin — 2.0% vs -24.1%, a 26.1% gap on every dollar of revenue. On growth, LCI INDUSTRIES posted the faster year-over-year revenue change (16.1% vs 12.2%). LCI INDUSTRIES produced more free cash flow last quarter ($64.3M vs $46.0M). Over the past eight quarters, LCI INDUSTRIES's revenue compounded faster (-1.8% CAGR vs -2.6%).
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.
Lucky Core Industries Limited, formerly known as ICI Pakistan, is a Pakistani conglomerate company headquartered in Karachi. It manufactures polyester, pharmaceutical, agrochemical, soda ash, and veterinary medicine.
ELAN vs LCII — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $932.7M |
| Net Profit | $-276.0M | $18.7M |
| Gross Margin | 51.5% | 22.1% |
| Operating Margin | -22.6% | 3.8% |
| Net Margin | -24.1% | 2.0% |
| Revenue YoY | 12.2% | 16.1% |
| Net Profit YoY | -3350.0% | 95.7% |
| EPS (diluted) | $-0.55 | $0.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $932.7M | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.0B | $803.1M | ||
| Q3 24 | $1.0B | $915.5M | ||
| Q2 24 | $1.2B | $1.1B | ||
| Q1 24 | $1.2B | $968.0M |
| Q4 25 | $-276.0M | $18.7M | ||
| Q3 25 | $-34.0M | $62.5M | ||
| Q2 25 | $11.0M | $57.6M | ||
| Q1 25 | $67.0M | $49.4M | ||
| Q4 24 | $-8.0M | $9.5M | ||
| Q3 24 | $364.0M | $35.6M | ||
| Q2 24 | $-50.0M | $61.2M | ||
| Q1 24 | $32.0M | $36.5M |
| Q4 25 | 51.5% | 22.1% | ||
| Q3 25 | 53.4% | 24.4% | ||
| Q2 25 | 57.5% | 24.4% | ||
| Q1 25 | 57.3% | 24.1% | ||
| Q4 24 | 50.9% | 21.1% | ||
| Q3 24 | 52.2% | 24.0% | ||
| Q2 24 | 58.2% | 25.3% | ||
| Q1 24 | 57.3% | 23.1% |
| Q4 25 | -22.6% | 3.8% | ||
| Q3 25 | -4.4% | 7.3% | ||
| Q2 25 | 2.0% | 7.9% | ||
| Q1 25 | 5.0% | 7.8% | ||
| Q4 24 | -5.0% | 2.0% | ||
| Q3 24 | 54.3% | 5.9% | ||
| Q2 24 | -2.7% | 8.6% | ||
| Q1 24 | 1.0% | 6.0% |
| Q4 25 | -24.1% | 2.0% | ||
| Q3 25 | -3.0% | 6.0% | ||
| Q2 25 | 0.9% | 5.2% | ||
| Q1 25 | 5.6% | 4.7% | ||
| Q4 24 | -0.8% | 1.2% | ||
| Q3 24 | 35.3% | 3.9% | ||
| Q2 24 | -4.2% | 5.8% | ||
| Q1 24 | 2.7% | 3.8% |
| Q4 25 | $-0.55 | $0.79 | ||
| Q3 25 | $-0.07 | $2.55 | ||
| Q2 25 | $0.02 | $2.29 | ||
| Q1 25 | $0.13 | $1.94 | ||
| Q4 24 | $-0.01 | $0.37 | ||
| Q3 24 | $0.73 | $1.39 | ||
| Q2 24 | $-0.10 | $2.40 | ||
| Q1 24 | $0.06 | $1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $545.0M | $222.6M |
| Total DebtLower is stronger | $3.9B | $945.2M |
| Stockholders' EquityBook value | $6.5B | $1.4B |
| Total Assets | $13.4B | $3.2B |
| Debt / EquityLower = less leverage | 0.60× | 0.69× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $545.0M | $222.6M | ||
| Q3 25 | $505.0M | $199.7M | ||
| Q2 25 | $539.0M | $191.9M | ||
| Q1 25 | $487.0M | $231.2M | ||
| Q4 24 | $468.0M | $165.8M | ||
| Q3 24 | $490.0M | $161.2M | ||
| Q2 24 | $416.0M | $130.4M | ||
| Q1 24 | $345.0M | $22.6M |
| Q4 25 | $3.9B | $945.2M | ||
| Q3 25 | $4.0B | $947.8M | ||
| Q2 25 | $4.1B | $948.0M | ||
| Q1 25 | $4.4B | $938.3M | ||
| Q4 24 | $4.3B | $757.3M | ||
| Q3 24 | $4.4B | $822.5M | ||
| Q2 24 | $5.7B | $829.7M | ||
| Q1 24 | $5.8B | $855.3M |
| Q4 25 | $6.5B | $1.4B | ||
| Q3 25 | $6.7B | $1.4B | ||
| Q2 25 | $6.8B | $1.4B | ||
| Q1 25 | $6.4B | $1.4B | ||
| Q4 24 | $6.1B | $1.4B | ||
| Q3 24 | $6.5B | $1.4B | ||
| Q2 24 | $5.9B | $1.4B | ||
| Q1 24 | $6.1B | $1.4B |
| Q4 25 | $13.4B | $3.2B | ||
| Q3 25 | $13.6B | $3.2B | ||
| Q2 25 | $13.7B | $3.2B | ||
| Q1 25 | $12.9B | $3.1B | ||
| Q4 24 | $12.6B | $2.9B | ||
| Q3 24 | $13.3B | $3.0B | ||
| Q2 24 | $13.8B | $3.0B | ||
| Q1 24 | $14.0B | $3.0B |
| Q4 25 | 0.60× | 0.69× | ||
| Q3 25 | 0.59× | 0.70× | ||
| Q2 25 | 0.61× | 0.68× | ||
| Q1 25 | 0.69× | 0.69× | ||
| Q4 24 | 0.70× | 0.55× | ||
| Q3 24 | 0.67× | 0.58× | ||
| Q2 24 | 0.96× | 0.60× | ||
| Q1 24 | 0.95× | 0.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.0M | $78.9M |
| Free Cash FlowOCF − Capex | $46.0M | $64.3M |
| FCF MarginFCF / Revenue | 4.0% | 6.9% |
| Capex IntensityCapex / Revenue | 5.4% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 4.22× |
| TTM Free Cash FlowTrailing 4 quarters | $284.0M | $278.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.0M | $78.9M | ||
| Q3 25 | $219.0M | $97.2M | ||
| Q2 25 | $237.0M | $112.2M | ||
| Q1 25 | $-4.0M | $42.7M | ||
| Q4 24 | $177.0M | $106.6M | ||
| Q3 24 | $162.0M | $78.4M | ||
| Q2 24 | $200.0M | $192.9M | ||
| Q1 24 | $2.0M | $-7.7M |
| Q4 25 | $46.0M | $64.3M | ||
| Q3 25 | $127.0M | $80.9M | ||
| Q2 25 | $180.0M | $99.5M | ||
| Q1 25 | $-69.0M | $33.7M | ||
| Q4 24 | $130.0M | $95.7M | ||
| Q3 24 | $120.0M | $68.3M | ||
| Q2 24 | $166.0M | $180.2M | ||
| Q1 24 | $-22.0M | $-16.3M |
| Q4 25 | 4.0% | 6.9% | ||
| Q3 25 | 11.2% | 7.8% | ||
| Q2 25 | 14.5% | 9.0% | ||
| Q1 25 | -5.8% | 3.2% | ||
| Q4 24 | 12.7% | 11.9% | ||
| Q3 24 | 11.7% | 7.5% | ||
| Q2 24 | 14.0% | 17.1% | ||
| Q1 24 | -1.8% | -1.7% |
| Q4 25 | 5.4% | 1.6% | ||
| Q3 25 | 8.1% | 1.6% | ||
| Q2 25 | 4.6% | 1.2% | ||
| Q1 25 | 5.4% | 0.9% | ||
| Q4 24 | 4.6% | 1.4% | ||
| Q3 24 | 4.1% | 1.1% | ||
| Q2 24 | 2.9% | 1.2% | ||
| Q1 24 | 2.0% | 0.9% |
| Q4 25 | — | 4.22× | ||
| Q3 25 | — | 1.55× | ||
| Q2 25 | 21.55× | 1.95× | ||
| Q1 25 | -0.06× | 0.86× | ||
| Q4 24 | — | 11.17× | ||
| Q3 24 | 0.45× | 2.20× | ||
| Q2 24 | — | 3.15× | ||
| Q1 24 | 0.06× | -0.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
LCII
| Travel Trailer And Fifth Wheels | $378.4M | 41% |
| Chassis Chassis Partsand Slideout Mechanisms | $206.1M | 22% |
| Furnitureand Mattresses | $120.4M | 13% |
| Appliances | $69.9M | 7% |
| Other Products | $69.1M | 7% |
| Axlesand Suspension Solutions | $62.3M | 7% |
| Motorhomes | $34.2M | 4% |
